4,17-Dioxabicyclo[14.1.0]heptadeca-6,14-diene-5,13-dione,2-[[(6-deoxy-2,3-di-O-methyl-b-D-allopyranosyl)oxy]methyl]-3-ethyl-2-hydroxy-8,10,12-trimethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(1R,2S,3R,6E,8S,9S,10S,12R,14E,16S)-
| Product Information | |
|---|---|
| Product Number: | AX-HK4W |
| Product Name: | 4,17-Dioxabicyclo[14.1.0]heptadeca-6,14-diene-5,13-dione,2-[[(6-deoxy-2,3-di-O-methyl-b-D-allopyranosyl)oxy]methyl]-3-ethyl-2-hydroxy-8,10,12-trimethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(1R,2S,3R,6E,8S,9S,10S,12R,14E,16S)- |
| CAS: | 73684-69-2 |
| MW: | 715.98 |
| Synonyms: | MycinamicinI, 14-hydroxy-; 4,17-Dioxabicyclo[14.1.0]heptadecane, mycinamicin I deriv.;Antibiotic A 11725II; Antibiotic AR 5-2; Miporamicin; Mirosamicin; Mirosamycin;Mycinamicin II; Mycinomycin II |
| EINECS: | |
| Density: | |
| Melting Point: | |
| Boiling Point: | |
| Flash Point: | |
| Solubility: | |
| Risk Codes: | |
| Transport Information:: | |